Advertisement

Topics

Neuralstem Inc. Company Profile

19:09 EDT 24th September 2017 | BioPortfolio

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia.


News Articles [26 Associated News Articles listed on BioPortfolio]

Neuralstem FOPO nets $5.6mm

CNS drug developer Neuralstem Inc. netted $5.6mm through a public offering of 3mm common shares at $2.00. The company also issued seven-year warrants redeemable for 2.25mm common shares at $2.00. Rece...

Neuralstem Announces Top-line Phase 2 Data of NSI-189 for Major Depressive Disorder

GERMANTOWN, Md., July 25, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced top-line results ...

Neuralstem Is Doomed

Neuralstem's NSI-189 misses in Phase II for MDD

Neuralstem Announces Issuance of Two U.S. Patents

GERMANTOWN, Md., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has...

Neuralstem sags after Phase II miss in MDD

NeuralStem Announces Issuance Of Two U.S. Patents

  Life Sciences Jobs   ...

Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder

GERMANTOWN, Md., May 17, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, today announced it ha...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

NeuralStem

Scientific founder and Chairman, Karl Johe, Ph.D. while at NINDS, NIH, originally developed Neuralstem’s technology. The Company’s other founders are current President & CEO Richard Garr, JD, and...

Neuralstem Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the d...

Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability...

More Information about "Neuralstem Inc." on BioPortfolio

We have published hundreds of Neuralstem Inc. news stories on BioPortfolio along with dozens of Neuralstem Inc. Clinical Trials and PubMed Articles about Neuralstem Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuralstem Inc. Companies in our database. You can also find out about relevant Neuralstem Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...


Corporate Database Quicklinks



Searches Linking to this Company Record